Breast cancer 'clearance' techniques suggested

March 4, 2014 by Lily Yeang, Science Network WA
Surgeons view mammography images along with using other intraoperative assessment methods to find cancer 'clearance'. Credit: Kristie Wells

AN investigation into the methods of checking that breast cancer is completely removed during surgery, has found some methods aren't affective at eliminating the need for a second surgery.

The review, published in the journal The Breast, examined the success rate of intraoperative assessment methods – frozen section, imprint/touch smear cytology and ultrasounds – used in .

Lead author and Curtin University's Kerryn Butler-Henderson says intraoperative methods help to determine how much of a tumour remains in the breast during the first operation.

"Where accurate, this means the tests not only reduce the need for a second operation but can potentially reduce the rate of recurrence or invasion," Ms Butler-Henderson says.

"Second operations are often required when the breast cancer is close or involved in one or more surgical margins.

"Research has shown that where an adequate margin has not been achieved there is an increased risk of recurrence or invasion."

She says it is important to ensure adequate margins have been obtained in surgery.

"The problem is this can be difficult to achieve as the surgeon only has mammography images to view and if the tumour is large enough they can palpate the tumour," she says.

"In many cases the patient will have a hookwire inserted to guide the surgeon but my epidemiological study has shown in ductal carcinoma in situ (DCIS) alone, 18 per cent of women [nearly one in five] will still need a second operation to obtain clearance."

To prevent patients having to come back for another operation, doctors use intraoperative methods to assess the area, checking that all infected tissue is removed.

"Although pathological methods, such as frozen section and imprint cytology performed well [in the studies reviewed], they added on average 20–30 minutes to operation times," Ms Butler-Henderson says.

"During imprint or touch smear cytology, [surgeons] 'rub' the margin surface onto a slide and look at that microscopically—the problem with this is not only does it take approximately 20 minutes, you cannot determine if there is a close margin, just if there is DCIS on the margin.

"An ultrasound probe allows accurate examination of the margins and delivers results in a timely manner, yet it has a limited role with DCIS where calcification is present and in multifocal cancer."

Ms Butler-Henderson instead recommends further research be undertaken in the use of digital mammography, radiofrequency spectroscopy, or .

"I have also been exploring, with success, the use of a (PET) probe in surgery," she says.

Explore further: Low rates of recurrence with 'no ink' as margin in breast CA

More information: "Intraoperative assessment of margins in breast conserving therapy: A systematic review." Kerryn Butler-Henderson, Andy H. Lee, Roger I. Price, Kaylene Waring. The Breast - 27 January 2014 (10.1016/j.breast.2014.01.002)

Related Stories

Low rates of recurrence with 'no ink' as margin in breast CA

February 14, 2014
(HealthDay)—Positive margins (ink on invasive carcinoma or ductal carcinoma in situ) are associated with increased risk of ipsilateral breast tumor recurrence (IBTR), according to consensus guidelines published online Feb. ...

MRI right before or after surgery does not benefit women with early breast cancer

September 4, 2013
Memorial Sloan-Kettering Cancer Center study shows that the use of MRI before or immediately after surgery in women with DCIS was not associated with reduced local recurrence or contralateral breast cancer rates. The findings ...

Examination of lymph nodes provides more accurate breast cancer prognosis

July 29, 2013
After a breast cancer operation, the removed tumour is always examined, as its subtype can provide an indication of how aggressive the disease is. The patient's lymph nodes are not analysed in the same way. Yet the breast ...

Margin threshold for women with ductal carcinoma in situ

March 22, 2012
Negative surgical margins should be attained for ductal carcinoma in situ (DCIS) patients after breast-conserving surgery (BCS) regardless of radiotherapy, and surgeons should attempt to reach wide negative margins in their ...

Ultrasound-guided surgery is best way to remove breast tumours

March 23, 2012
The use of ultrasound-guided surgery to remove tumours from women who have palpable breast cancer is much more successful than standard surgery in excising all the cancerous tissue while sparing as much healthy tissue as ...

Breast conserving treatment with radiotherapy reduces risk of local recurrence

September 18, 2013
Results of EORTC trial 10853 appearing in the Journal of Clinical Oncology show that breast conserving treatment combined with radiotherapy reduces the risk of local recurrence in women with ductal carcinoma in situ (DCIS). ...

Recommended for you

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

Dulling cancer therapy's double-edged sword

January 17, 2018
Researchers have discovered that killing cancer cells can actually have the unintended effect of fueling the proliferation of residual, living cancer cells, ultimately leading to aggressive tumor progression.

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

January 17, 2018
A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at ...

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.